Earnings History Data for AbbVie Inc. (ABBV) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

AbbVie Inc.

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
25-07-2024 PM ABBV AbbVie Inc. 305,760 2.65 2.56 2.91 AbbVie Non-GAAP EPS of $2.65 misses by $0.01, revenue of $14.46B beats by $430M
[7/25/2024 7:37 AM]
182.52 6.31 
(3.58%)
174.00 -2.21 
(-1.25%)
135.85 - 186.11 7,483,847 4,440,000 44,042
26-04-2024 PM ABBV AbbVie Inc. 296,410 2.31 2.35 2.46 AbbVie Non-GAAP EPS of $2.31 beats by $0.05, revenue of $12.31B beats by $370M
[4/26/2024 7:36 AM]
159.54 -7.75 
(-4.63%)
166.49 -0.80 
(-0.48%)
130.96 - 182.89 8,943,996 5,140,000 54,821
02-02-2024 PM ABBV AbbVie Inc. 290,250 2.79 2.76 3.60 AbbVie reports mixed Q4 results; raises FY24 outlook
[2/2/2024 7:41 AM]
168.64 1.05 
(0.63%)
168.96 1.37 
(0.82%)
130.96 - 172.85 6,230,525 5,020,000 76,139
27-10-2023 PM ABBV AbbVie Inc. 258,240 2.95 2.85 3.66 AbbVie Non-GAAP EPS of $2.95 beats by $0.08, revenue of $13.93B beats by $220M
[10/27/2023 7:39 AM]
138.93 -6.27 
(-4.32%)
136.87 -8.33 
(-5.74%)
130.96 - 168.11 7,463,257 4,700,000 100,141
27-07-2023 PM ABBV AbbVie Inc. 252,610 2.91 2.79 3.51 AbbVie Non-GAAP EPS of $2.91 beats by $0.10, revenue of $13.87B beats by $350M
[7/27/2023 7:39 AM]
148.85 6.95 
(4.90%)
144.00 2.10 
(1.48%)
130.96 - 168.11 10,828,942 5,130,000 309,718
27-04-2023 PM 7:45 AM ET
(Apr 27)
ABBV AbbVie Inc. 290,910 2.46 2.44 3.16 AbbVie Non-GAAP EPS of $2.46 misses by $0.03, revenue of $12.23B in-line
[4/27/2023 7:34 AM]
149.04 -12.76 
(-7.89%)
155.50 -6.30 
(-3.89%)
134.09 - 168.11 14,189,523 4,560,000 521,095
09-02-2023 PM 7:45 AM ET
(Feb 9)
ABBV AbbVie Inc. 256,680 3.60 3.54 3.31 AbbVie Non-GAAP EPS of $3.60 beats by $0.02, revenue of $15.12B misses by $180M, initiates FY outlook
[2/9/2023 7:45 AM]
148.70 4.09 
(2.83%)
147.77 3.16 
(2.19%)
134.09 - 175.91 10,197,853 5,300,000 307,866
28-10-2022 PM 7:40 AM ET
(Oct 28)
ABBV AbbVie Inc. 269,650 3.66 3.56 3.33 AbbVie Non-GAAP EPS of $3.66 beats by $0.10, revenue of $14.81B misses by $130M, raises dividend by 5%
[10/28/2022 7:45 AM]
147.50 -6.00 
(-3.91%)
146.00 -7.50 
(-4.89%)
108.20 - 175.91 9,191,067 4,740,000 174,215
29-07-2022 PM 7:45 AM ET
(Jul 29)
ABBV AbbVie Inc. 262,360 3.51 3.42 3.11 AbbVie Non-GAAP EPS of $3.37 beats by $0.06, revenue of $14.58B misses by $60M, cuts FY22 EPS guidance
[7/29/2022 7:43 AM]
143.65 -6.10 
(-4.07%)
146.70 -3.05 
(-2.04%)
105.56 - 175.91 15,064,137 5,030,000 31,351
29-04-2022 PM 7:45 AM ET
(Apr 29)
ABBV AbbVie Inc. 278,400 3.16 3.15 2.95 AbbVie Non-GAAP EPS of $3.16 beats by $0.02, revenue of $13.54B misses by $70M
[4/29/2022 7:44 AM]
146.85 -9.46 
(-6.05%)
148.93 -7.38 
(-4.72%)
105.56 - 175.91 20,338,728 7,630,000 209,424
02-02-2022 PM 7:40 AM ET
(Feb 2)
ABBV AbbVie Inc. 243,830 3.31 3.28 2.92 AbbVie Non-GAAP EPS of $3.31 beats by $0.03, revenue of $14.89B misses by $70M
[2/2/2022 7:45 AM]
138.81 1.81 
(1.32%)
136.34 -0.66 
(-0.48%)
102.05 - 139.41 9,440,816 8,710,000 288,029
29-10-2021 PM 7:45 AM ET
(Oct 29)
ABBV AbbVie Inc. 193,490 3.33 3.23 2.83 AbbVie EPS beats by $0.11, beats on revenue, raises guidance
[10/29/2021 7:43 AM]
114.53 4.86 
(4.43%)
111.96 2.29 
(2.09%)
79.11 - 121.53 13,233,217 5,310,000 241,915
30-07-2021 PM 7:40 AM ET
(Jul 30)
ABBV AbbVie Inc. 209,390 3.11 3.11 2.34 AbbVie EPS beats by $0.08, beats on revenue, raises FY21 Non-GAAP guidance
[7/30/2021 7:45 AM]
116.24 -2.63 
(-2.21%)
119.00 0.13 
(0.11%)
79.11 - 119.15 7,001,281 5,180,000 37,987
30-04-2021 PM 7:40 AM ET
(Apr 30)
ABBV AbbVie Inc. 196,670 2.95 2.77 2.42 AbbVie EPS beats by $0.12, beats on revenue
[4/30/2021 7:43 AM]
111.46 0.57 
(0.51%)
111.51 0.62 
(0.56%)
79.11 - 113.41 7,122,910 5,460,000 101,920
03-02-2021 PM 7:45 AM ET
(Feb 3)
ABBV AbbVie Inc. 180,610 2.92 2.85 2.21 AbbVie EPS beats by $0.07, beats on revenue
[2/3/2021 7:39 AM]
107.53 2.53 
(3.92%)
106.00 2.53 
(2.45%)
62.55 - 113.41 10,122,068 7,744,182 202,692
30-10-2020 PM 7:45 AM ET
(Oct 30)
ABBV AbbVie Inc. 148,850 2.83 2.75 2.33 AbbVie EPS beats by $0.06, beats on revenue
[10/30/2020 7:49 AM]
85.13 4.46 
(5.53%)
83.60 2.93 
(3.63%)
62.55 - 101.28 13,851,210 7,972,976 209,880
31-07-2020 PM 7:45 AM ET
(Jul 31)
ABBV AbbVie Inc. 170,970 2.34 2.24 2.26 AbbVie EPS beats by $0.14, beats on revenue
[7/31/2020 7:46 AM]
94.06 -1.98 
(-2.06%)
96.29 0.25 
(0.26%)
62.55 - 101.28 4,962,822 5,759,455 122,320